Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cs Shreedhara is active.

Publication


Featured researches published by Cs Shreedhara.


Pharmacognosy Research | 2010

Standardization of Ajmodadi churna, a polyherbal formulation.

Neeraj K Sriwastava; Cs Shreedhara; Hn Aswatha Ram

Standardization of herbal formulations is essential in order to assess the quality of drugs, based on the concentration of their active principles. This article reports on standardization of Ajmodadi churna, a polyherbal ayurvedic medicine used as a carminative and an antispasmodic, and is a strong wormifuge, and helps in all painful conditions like sciatica and stiffness in back and also restores normal digestive functions. Ajmodadi churna was prepared as per Ayurvedic Formulary of India. In-house preparation and the marketed drug have been standardized on the basis of organoleptic characters, physical characteristics, and physico-chemical properties. The set parameters were found to be sufficient to evaluate the churna and can be used as reference standards for the quality control/quality assurance laboratory of a Pharmaceutical house.


Ancient Science of Life | 2013

Pharmacognostic and phytochemical investigation of the leaves of Malvastrum coromandelianum (L.) Garcke.

Dhirendra B Sanghai; S. Vijaya Kumar; K. K. Srinivasan; Hn Aswatharam; Cs Shreedhara

Background: Malvastrum coromandelianum belongs to the family Malvaceae, commonly known as false mallow. Ethnobotanical survey revealed that it is used to treat various disorders. Pharmacological screening revealed that the plant possess antinoceceptive, anti-inflammatory, analgesic, and antibacterial activities. Lack of standardization parameters for herbal raw material is a great hindrance in ensuring the purity of M. coromandelianum. The present work was taken up to with a focus to set standardization parameters for M. coromandelianum. Materials and Methods: The plant was subjected to macroscopic and microscopic studies. Physicochemical parameters such as ash value and extractive value were determined by standard procedures. Different extracts were screened for the presence of secondary metabolites. Phenolic and flavonoid contents were estimated. Plant was subjected for high performance thin layer chromatography (HPTLC) analysis using standard chromatographic procedure. Result: The microscopic characteristics showed the dorsiventral nature of leaf. Two types of trichomes were observed: Covering, unicellular, uniseriate, and bi-cellular head sessile glandular. Vascular bundle was surrounded by spongy parenchyma. Phytochemical screening revealed the presence alkaloids, tannins, amino acid proteins, and carbohydrates. The phenolic and flavonoid content estimation revealed the presence of appreciable amount of these constituents, while HPTLC analysis showed the presence of β-sitosterol in petroleum ether extract. Conclusion: These findings will be useful for the establishment of standardization parameters for M. coromandelianum.


Journal of Ayurveda and Integrative Medicine | 2012

Anti-infl ammatory activity of Ajmodadi Churna extract against acute infl ammation in rats.

Hn Aswatha Ram; Neeraj K Sriwastava; Inder Kumar Makhija; Cs Shreedhara

Background: Ayurvedic polyherbal formulations are widely prescribed for a wide range of inflammatory conditions, yet, despite widespread use, there has been no systematic documentation of their safety and efficacy. Objective: The present study was undertaken to evaluate the anti-inflammatory activity of aqueous extracts of Ajmodadi churna (AJM) in rats. Materials and Methods: Carrageenan-induced hind paw edema and air pouch inflammation models were used for the study. Results: The extracts showed significant antiinflammatory activity, reducing paw edema volume by 0.417 ± 0.097 and 0.379 ± 0.049, respectively. In the carrageenan-induced air pouch model, AJM reduced total leukocyte count by 73.09 ± 7.13 and 62.17 ± 10.53, granulocyte count by 69.48 ± 5.44 and 63.33 ± 4.13, and myeloperoxidase activity by 14.84 ± 0.91 and 18.44 ± 3.18, respectively, compared to controls. Discussion and Conclusion: AJM significantly reduced paw edema, during the second phase of edema development. In the carrageenan-induced air pouch model, AJM inhibited cellular infiltration into the air pouch fluid. We conclude that AJM is an effective candidate for prevention or treatment of acute inflammation


Asian pacific Journal of Tropical Biomedicine | 2012

Histological and physiochemical standardization of Melia azedarach. Linn bark

S. Vijaya Kumar; Dhirendra B Sanghai; C. Mallikarjuna Rao; Cs Shreedhara

Objective To standardize Melia azedarach L. by detailed study of macorscopical, microscopical and physiochemical parameters.


Pharmacognosy Research | 2010

Formulation and evaluation of floating tablets of liquorice extract

H. N. A. Ram; Prachiti Lachake; Ujjwal Kaushik; Cs Shreedhara

Background: Floating tablets prolong the gastric residence time of drugs, improve bioavailability, and facilitate local drug delivery to the stomach. With this objective, floating tablets containing aqueous extract of liquorice as drug was prepared for the treatment of Helicobacter pylori and gastric ulcers. Methods: The aqueous extract of liquorice was standardized by HPTLC. Tablets containing HPMC K100M (hydrophilic polymer), liquorice extract, sodium bicarbonate (gas generating agent), talc, and magnesium stearate were prepared using direct compression method. The formulations were evaluated for physical parameters like diameter, thickness, hardness, friability, uniformity of weight, drug content, buoyancy time, dissolution, and drug release mechanism. The formulations were optimized on the basis of buoyancy time and in vitro drug release. Results: The diameter of all formulations was in the range 11.166–11.933 mm; thickness was in the range 4.02–4.086 mm. The hardness ranged from 3.1 to 3.5 kg/cm2. All formulations passed the USP requirements for friability and uniformity of weight. The buoyancy time of all tablet formulations was less than 5 min and tablet remained in floating condition throughout the study. All the tablet formulations followed zero-order kinetics and Korsemeyer-Peppas model in drug release. Conclusion: The optimized formulation was found to be F6 which released 98.3% of drug in 8 h in vitro, while the buoyancy time was 3.5 min. Formulations containing psyllium husk, sodium bicarbonate and HPMC K100M in combination can be a promising for gastroretentive drug delivery systems.


Pharmacognosy Magazine | 2015

Cytotoxic Activity of Macrosolen Parasiticus (L.) Danser on the Growth of Breast Cancer Cell Line (MCF‑7)

Vijay Sodde; Richard Lobo; Nimmy Kumar; Rajalekshmi Maheshwari; Cs Shreedhara

Background: Macrosolen parasiticus (L.) Danser belonging to Loranthaceaea (mistletoe family) is a parasitic plant that grows on different host plants such as mango, jack fruit, peepal, neem tree, etc., This study was aimed to investigate the anti-cancer activity of methanolic and aqueous extract of stem of M. parasiticus. Objectives: To investigate the in vitro cytotoxic potential of the methanolic and aqueous extracts from stems of M. parasiticus against MCF-7 breast cancer cells by brine shrimp lethality (BSL) bioassay, MTT assay and sulforhodamine B (SRB) assay. Materials and Methods: The extracts were tested in human breast cancer cell lines in vitro for percentage cytotoxicity, apoptosis by acridine orange/ethidium bromide staining, LD50 and IC50 values after treatment with M. parasiticus extracts. Results: In BSL bioassay, aqueous extract showed more significant (P < 0.01) cytotoxicity with LD50 82.79 ± 2.67 μg/mL as compared to methanolic extract with LD50 125 ± 3.04 μg/mL. The methanolic extract of M. parasiticus showed IC50 97.33 ± 3.75 μg/mL (MTT) (P < 0.05) and 94.58 ± 3.84 μg/mL (SRB) (P < 0.01) assays against MCF-7. The aqueous extract of M. parasiticus demonstrated higher activity with IC50 59.33 ± 3.3 μg/mL (MTT) (P < 0.01) and 51.9 ± 1.87 μg/mL (SRB)(P < 0.01) assays, after 48 h of exposure and thus showed significant dose-dependent cytotoxic activity. Conclusion: The finding demonstrated that both extracts of M. parasiticus showed significant cytotoxic activity, however aqueous extract demonstrated higher activity against MCF-7 breast cancer cells.


Pharmacognosy Research | 2013

Mast cell stabilization potential of Sitopaladi churna: An ayurvedic formulation

Inder Kumar Makhija; Cs Shreedhara; Hn Aswatha Ram

Background: Sitopaladi churna (SPC) is a popular polyherbal ayurvedic formulation used in the treatment of allergy and respiratory diseases. Objective: The present study was aimed to justify the classical use of antiallergic claim by performing the mast cell stabilizing activity of extracts of SPC. Materials and Methods: The protective effect of aqueous extract and methanolic extract - of SPC against compound 48/80-induced mast cell degranulation model was carried out. Results: Sitopaladi churna aqueous extract (SPCA) at the dose of 300 mg/kg and Sitopaladi churna methanolic extract (SPCM) at the doses of 150 and 300 mg/kg showed better protection of mast cell degranulation (65%-74%) and were comparable to the standard drug ketotifen (79%), when peritoneal mast cells were treated with compound 48/80. The protection against mast cell degranulation was significant (P < 0.0001). Conclusion: From the above results, it has been justified that SPC can be used to treat allergic disorders.


Pharmacognosy Magazine | 2017

Characterization of the phenolic compound, gallic acid from sansevieria roxburghiana schult and schult. f. rhizomes and antioxidant and cytotoxic activities evaluation

Rajalekshmi Maheshwari; Cs Shreedhara; Picheswara P Rao; Renuka S. Managuli; Seena Kanniparambil Xavier; L Richard; M. Manjunath Setty; Srinivas Mutalik

Background: Sansevieria roxburghiana Schult. and Schult. f. (Asparagaceae) grows in India, Indonesia, Sri Lanka, and tropical Africa. Even though the plant has been traditionally used for the treatment of many ailments, the antioxidant and antiproliferative activities of S. roxburghiana methanol extract and its fractions have not yet been explored. Materials and Methods: Quantitative estimation of phenols and different antioxidant assays were performed using standard methods. Anti-proliferative effect of the extract and fractions were evaluated in HCT-116, HeLa, MCF-7, HepG2, and A-549 cancer cell lines by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and sulforhodamine B (SRB) assay methods. High-performance liquid chromatography (HPLC) and high-performance thin layer chromatography (HPTLC) fingerprint profiling were carried out for extract and different fractions. Results: Significant antioxidant and anti-proliferate activity were detected in ethyl acetate fraction. Ethyl acetate fraction showed prominent scavenging activity in 1,1-diphenyl-2-picrylhydrazyl, 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt, and nitric oxide antioxidant assays with an concentration yielding 50% inhibition (IC50) 15.33 ± 1.45, 45.3 ± 1.93 and 48.43 ± 0.46 μ g/ml, respectively. Cytotoxicity of ethyl acetate fraction was the highest among other fractions against HCT-116, HeLa, and MCF-7cancer cell lines with IC50values 16.55 ± 1.28, 12.38 ± 1.36, and 8.03 ± 1.9 μ g/ml, respectively, by MTT assay and 15.57 ± 0.70, 13.19 ± 0.49, and 10.34 ± 0.9 μ g/ml, respectively, by SRB assay. The presence of gallic acid in the ethyl acetate fraction of S. roxburghiana rhizomes was confirmed by HPLC and HPTLC analysis. Conclusion: Results suggested that ethyl acetate fraction exhibited effective antioxidant and antiproliferative activities. The phenolic compounds identified in ethyl acetate fraction could be responsible for the activities. Abbreviations used: %: Percent, °C: Celsius, μ g: Microgram, μ l-Microlitre, ANOVA: Analysis of variance, DMSO: Dimethyl sulfoxide, g: Grams, IC50: Concentration yielding 50% inhibition, Kg: Kilogram, mg: Milligram, min: Minutes, ml: Milliliter, HPLC: High-performance liquid chromatography, HPTLC: High-performance thin layer chromatography, DPPH: 1,1-diphenyl-2-picrylhydrazyl, ABTS: 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt, MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, GAE: Gallic acid equivalents, SRME: Methanol extract of S. roxburghiana, ROS: Reactive oxygen species, SRPE: Petroleum ether fraction of S. roxburghiana, SREA: Ethyl acetate fraction of S. roxburghiana, SRAQ: Aqueous fraction of S. roxburghiana, DMEM: Dulbeccos Minimum Essential Medium, FBS: Fetal bovine serum, OD: Optical density, TPC: Total phenolic content, SRBU: Butanol fraction of S. roxburghiana.


Ancient Science of Life | 2012

Physico-chemical standardization of Sitopaladi churna

Inder Kumar Makhija; Cs Shreedhara; Holavana Hally Nanjundaiah Setty Aswatha Ram

Background: Standardization of a compound Ayurvedic formulation is a critical and essential issue to be considered in assuring the therapeutic efficacy and safety and to rationalize their use in the health care. Sitopaladi churna is a reputed polyherbal formulation of Ayurveda. It is prescribed for the treatment of pleurodynia, intercostal neuralgia, cold, cough associated with bronchitis, pneumonia, tuberculosis, viral respiratory infection, and in pharyngeal and chest congestion. Objective: The present study aimed at physico-chemical standardization of in-house and two marketed brands of Sitopaladi churna. Materials and Methods: In our investigation, in-house churna and two commercial brands of Sitopaladi churna were standardized based on powder microscopy, physico-chemical evaluations, thin layer chromatography (TLC) and high performance thin layer chromatography (HPTLC) finger printing as per standard procedures. Results: The set parameters were sufficient to evaluate the churna based on various physico-chemical parameters. Conclusion: The data evolved can be adopted for laying down the standards for the manufacturing units of Sitopaladi churna.


Free Radicals and Antioxidants | 2011

In vitro antioxidant studies of Sitopaladi Churna, a polyherbal Ayurvedic formulation

Inder Kumar Makhija; Hn Aswatha Ram; Cs Shreedhara; S. Vijay Kumar; Raviraj Anand Devkar

Collaboration


Dive into the Cs Shreedhara's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge